The pharmaceutical industry experienced a period ... resulting in bankruptcies, job losses, and depressed valuations. Now, it appears that the malaise is creeping to almost all areas of the ...

U.S. President Donald Trump on Wednesday accused Ireland of stealing pharmaceutical jobs and tax revenues from the United ...

New Jersey's powerful pharmaceutical industry, already under pressure to rein in prices, is facing new headwinds from a Trump ...

The New Jersey Economic Development Authority board March 12 approved $5.24 million in tax credits under the Emerge Program ...

Board approved tax credits under the Emerge Program to support Sun Pharmaceutical Industries Inc.’s plan to open a new head ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

US pharmaceutical companies based in Ireland are more likely to shift profits back to the US than close manufacturing plants ...

The NJEDA Board approved tax credits under the Emerge Program to support Sun Pharmaceutical Industries Inc.’s plan to open a new ...

Layoffs are a fact of life in the pharma and biotech industries with companies frequently adjusting headcount as their priorities shift. But the steady stream of cuts grew stronger last year as ...

Most organizations can afford a 10% efficiency cut, providing immediate financial relief, but how these cuts are done often ...

Paired with the current US pharmaceutical job vacancy rate of around 8%, companies will need to pivot to fill the incredible labour needs. So, what are the driving factors for growth in the industry?

K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.